Literature DB >> 30850547

Evolution of the Pseudomonas aeruginosa quorum-sensing hierarchy.

Maxim Kostylev1, Daniel Y Kim1, Nicole E Smalley2, Indraneel Salukhe1, E Peter Greenberg3, Ajai A Dandekar3,2.   

Abstract

The bacterial pathogen Pseudomonas aeruginosa activates expression of many virulence genes in a cell density-dependent manner by using an intricate quorum-sensing (QS) network. QS in P. aeruginosa involves two acyl-homoserine-lactone circuits, LasI-LasR and RhlI-RhlR. LasI-LasR is required to activate many genes including those coding for RhlI-RhlR. P. aeruginosa causes chronic infections in the lungs of people with cystic fibrosis (CF). In these infections, LasR mutants are common, but rhlR-rhlI expression has escaped LasR regulation in many CF isolates. To better understand the evolutionary trajectory of P. aeruginosa QS in chronic infections, we grew LasR mutants of the well-studied P. aeruginosa strain, PAO1, in conditions that recapitulate an environment where QS signal synthesis by other bacteria might still occur. When QS is required for growth, addition of the RhlI product butyryl-homoserine lactone (C4-HSL), or bacteria that produce C4-HSL, to LasR mutants results in the rapid emergence of a population with a LasR-independent RhlI-RhlR QS system. These evolved populations exhibit subsequent growth without added C4-HSL. The variants that emerge have mutations in mexT, which codes for a transcription factor that controls expression of multiple genes. LasR-MexT mutants have a competitive advantage over both the parent LasR mutant and a LasR-MexT-RhlR mutant. Our findings suggest a plausible evolutionary trajectory for QS in P. aeruginosa CF infections where LasR mutants arise during infection, but because these mutants are surrounded by C4-HSL-producing P. aeruginosa, variants rewired to have a LasR-independent RhlIR system quickly emerge.

Entities:  

Keywords:  LasR; RhlR; acyl-homoserine lactone; cystic fibrosis; sociomicrobiology

Mesh:

Substances:

Year:  2019        PMID: 30850547      PMCID: PMC6452656          DOI: 10.1073/pnas.1819796116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Quorum sensing and policing of Pseudomonas aeruginosa social cheaters.

Authors:  Meizhen Wang; Amy L Schaefer; Ajai A Dandekar; E Peter Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

2.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

3.  Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa.

Authors:  E C Pesci; J B Milbank; J P Pearson; S McKnight; A S Kende; E P Greenberg; B H Iglewski
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Functions required for extracellular quinolone signaling by Pseudomonas aeruginosa.

Authors:  Larry A Gallagher; Susan L McKnight; Marina S Kuznetsova; Everett C Pesci; Colin Manoil
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

5.  Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients.

Authors:  Thomas Bjarnsholt; Peter Østrup Jensen; Tim Holm Jakobsen; Richard Phipps; Anne Kirstine Nielsen; Morten Theil Rybtke; Tim Tolker-Nielsen; Michael Givskov; Niels Høiby; Oana Ciofu
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

6.  Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients.

Authors:  David A D'Argenio; Manhong Wu; Lucas R Hoffman; Hemantha D Kulasekara; Eric Déziel; Eric E Smith; Hai Nguyen; Robert K Ernst; Theodore J Larson Freeman; David H Spencer; Mitchell Brittnacher; Hillary S Hayden; Sara Selgrade; Mikkel Klausen; David R Goodlett; Jane L Burns; Bonnie W Ramsey; Samuel I Miller
Journal:  Mol Microbiol       Date:  2007-04       Impact factor: 3.501

7.  Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection.

Authors:  H B Tang; E DiMango; R Bryan; M Gambello; B H Iglewski; J B Goldberg; A Prince
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

8.  Emergence of the P2 phenotype in Pseudomonas aeruginosa PAO1 strains involves various mutations in mexT or mexF.

Authors:  Preston M Luong; Benjamin D Shogan; Alexander Zaborin; Natalia Belogortseva; Joshua D Shrout; Olga Zaborina; John C Alverdy
Journal:  J Bacteriol       Date:  2013-11-15       Impact factor: 3.490

9.  Precision-engineering the Pseudomonas aeruginosa genome with two-step allelic exchange.

Authors:  Laura R Hmelo; Bradley R Borlee; Henrik Almblad; Michelle E Love; Trevor E Randall; Boo Shan Tseng; Chuyang Lin; Yasuhiko Irie; Kelly M Storek; Jaeun Jane Yang; Richard J Siehnel; P Lynne Howell; Pradeep K Singh; Tim Tolker-Nielsen; Matthew R Parsek; Herbert P Schweizer; Joe J Harrison
Journal:  Nat Protoc       Date:  2015-10-22       Impact factor: 13.491

10.  Stationary phase-specific virulence factor overproduction by a lasR mutant of Pseudomonas aeruginosa.

Authors:  Matthew T Cabeen
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

View more
  58 in total

Review 1.  Virulence attenuating combination therapy: a potential multi-target synergy approach to treat Pseudomonas aeruginosa infections in cystic fibrosis patients.

Authors:  Elana Shaw; William M Wuest
Journal:  RSC Med Chem       Date:  2020-02-19

2.  The Rhl Quorum-Sensing System Is at the Top of the Regulatory Hierarchy under Phosphate-Limiting Conditions in Pseudomonas aeruginosa PAO1.

Authors:  Martín Paolo Soto-Aceves; Miguel Cocotl-Yañez; Luis Servín-González; Gloria Soberón-Chávez
Journal:  J Bacteriol       Date:  2021-02-08       Impact factor: 3.490

3.  Social cheating in a Pseudomonas aeruginosa quorum-sensing variant.

Authors:  Ruiyi Chen; Eric Déziel; Marie-Christine Groleau; Amy L Schaefer; E Peter Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-07       Impact factor: 11.205

4.  Pseudomonas aeruginosa mexT is an indicator of PAO1 strain integrity.

Authors:  Eric D LoVullo; Herbert P Schweizer
Journal:  J Med Microbiol       Date:  2019-12-18       Impact factor: 2.472

5.  Tobramycin Adaptation Enhances Policing of Social Cheaters in Pseudomonas aeruginosa.

Authors:  Rhea G Abisado; John H Kimbrough; Brielle M McKee; Vaughn D Craddock; Nicole E Smalley; Ajai A Dandekar; Josephine R Chandler
Journal:  Appl Environ Microbiol       Date:  2021-05-26       Impact factor: 4.792

Review 6.  Bacterial signaling as an antimicrobial target.

Authors:  Melissa Ellermann; Vanessa Sperandio
Journal:  Curr Opin Microbiol       Date:  2020-09-08       Impact factor: 7.934

Review 7.  The social life of microbes in chronic infection.

Authors:  Carolyn B Ibberson; Marvin Whiteley
Journal:  Curr Opin Microbiol       Date:  2020-03-04       Impact factor: 7.934

8.  Allelic polymorphism shapes community function in evolving Pseudomonas aeruginosa populations.

Authors:  Sheyda Azimi; Aled E L Roberts; Shengyun Peng; Joshua S Weitz; Alan McNally; Samuel P Brown; Stephen P Diggle
Journal:  ISME J       Date:  2020-04-27       Impact factor: 10.302

9.  New insights into the antibacterial and quorum sensing inhibition mechanism of Artemisia argyi leaf extracts towards Pseudomonas aeruginosa PAO1.

Authors:  Junhao Kong; Yanan Wang; Kai Xia; Ning Zang; Hong Zhang; Xinle Liang
Journal:  3 Biotech       Date:  2021-01-27       Impact factor: 2.406

10.  Quorum sensing provides a molecular mechanism for evolution to tune and maintain investment in cooperation.

Authors:  Eric L Bruger; Daniel J Snyder; Vaughn S Cooper; Christopher M Waters
Journal:  ISME J       Date:  2020-12-20       Impact factor: 10.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.